持续葡萄糖监测应用的国际共识
本文为2017年2月先进技术与糖尿病治疗(ATTD)大会召集的国际专家组关于持续葡萄糖监测(CGM)的共识推荐,指出糖化血红蛋白(HbA1c)无法反映血糖波动,而实时CGM(rtCGM)或间歇查看CGM(iCGM)可弥补其局限,但CGM数据的标准化指标及匹配患者与监测方法的明确标准尚未建立,本文总结了该共识推荐及CGM结果影响结局的当前理解。
要点
- HbA1c不反映日内和日间血糖波动,后者可致低血糖等急性事件并与微血管及大血管并发症相关。
- rtCGM或iCGM可弥补HbA1c检测和自我血糖监测的许多局限。
- CGM数据标准化指标及匹配患者与最适监测方法的标准尚未建立,为本共识着力解决的问题。
核心结论
- 本文总结了ATTD共识推荐,代表当前对CGM结果如何影响结局的理解。
研究设计与样本
- 2017年2月,先进技术与糖尿病治疗(ATTD)大会召集由医生、研究人员及糖尿病个体组成的国际专家组制定共识。
主要发现
- HbA1c不反映可能导致急性事件(如低血糖)或餐后高血糖的日内和日间血糖波动,后者与微血管和大血管并发症相关。
- 实时CGM(rtCGM)或间歇查看CGM(iCGM)可解决HbA1c检测和自我血糖监测的许多局限。
- 分析CGM数据的标准化指标缺乏,匹配糖尿病患者与最适葡萄糖监测方法的明确标准及关于如何最佳使用新信息的标准化建议尚未建立。
关键数值与推荐
- 原文未报告具体推荐条款、推荐等级或关键数值。
临床怎么用
- 原文未据此给出具体临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Measurement of glycated hemoglobin (HbA1c) has been the traditional method for assessing glycemic control. However, it does not reflect intra- and interday glycemic excursions that may lead to acute events (such as hypoglycemia) or postprandial hyperglycemia, which have been linked to both microvascular and macrovascular complications. Continuous glucose monitoring (CGM), either from real-time use (rtCGM) or intermittently viewed (iCGM), addresses many of the limitations inherent in HbA1c testing and self-monitoring of blood glucose. Although both provide the means to move beyond the HbA1c measurement as the sole marker of glycemic control, standardized metrics for analyzing CGM data are lacking. Moreover, clear criteria for matching people with diabetes to the most appropriate glucose monitoring methodologies, as well as standardized advice about how best to use the new information they provide, have yet to be established. In February 2017, the Advanced Technologies & Treatments for Diabetes (ATTD) Congress convened an international panel of physicians, researchers, and individuals with diabetes who are expert in CGM technologies to address these issues. This article summarizes the ATTD consensus recommendations and represents the current understanding of how CGM results can affect outcomes.
引用
- Danne T, Nimri R, Battelino T, et al. International Consensus on Use of Continuous Glucose Monitoring. Diabetes Care. 2017. PMID: 29162583. doi:10.2337/dc17-1600
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。